Assessment of Patient Experience During Treatment for Cancer
- Pathologically diagnosed carcinoma patients at Stanford cancer center who signed the
informed consent form.
- Patients with a prognosis of < 6 months life expectancy
Type of Study:
Observational Model: Cohort, Time Perspective: Prospective
United States: Food and Drug Administration
|Stanford University Cancer Institute||Stanford, California 94305|